Testing an oral tablet for hard-to-control asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with asthma for at least 12 months.
- You need to be using a moderate-to-high dose inhaled steroid combined with another asthma controller medication for at least 3 months, and be stable for the past month.
- You must have had at least one asthma attack or flare-up in the last 12 months.
- Your lung function test (FEV1) must be less than 80% of the normal predicted value before using a rescue inhaler.
- Your asthma control questionnaire score must be 1.5 or higher (meaning your asthma is not well controlled).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.